Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer
| Autor: | Kim, Kenneth H., Jelovac, Danijela, Armstrong, Deborah K., Schwartz, Benjamin, Weil, Susan C., Schweizer, Charles, Alvarez, Ronald D. |
|---|---|
| Zdroj: | In Gynecologic Oncology February 2016 140(2):210-214 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect